Back to mobile site

J.P. Morgan Downgrades Keryx Biopharmaceuticals (KERX) to Neutral

March 10, 2008 6:59 AM EDT Send to a Friend
J.P. Morgan downgrades Keryx Biopharmaceuticals (Nasdaq: KERX) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login